Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 227

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Role of inflammation in diabetic complications

Navarro, Juan F., Mora, Carmen·2005·Nephrology Dialysis Transplantation

Abstract

Diabetes mellitus, especially type 2 diabetes, is a public health problem which has reached epidemic proportions due to the rapidly increasing rates of this disease worldwide. Target organ complications, secondary to diabetes, will be one of the most important medical concerns of the coming decades. A clear example is diabetic nephropathy (DN), which has become the single most frequent cause of end-stage renal disease, in other words: ‘a medical catastrophe of worldwide dimensions’ [1]. In the last few years, our knowledge of DN and its clinical course, the factors that influence it as well as the progression of renal injury and the possibilities of effective therapeutic approaches have substantially improved. From a pathophysiological point of view, the critical importance of metabolic and haemodynamic factors for the risk of developing DN is clear. However, the intimate mechanisms leading from chronic hyperglycaemia to the development of renal injury are complex and not yet fully unravelled. In 1998, a hypothesis was proposed suggesting that long-term innate immune system activation, resulting in chronic inflammation, elicited disease instead of repair, leading to the development of type 2 diabetes [2]. In the last few years, numerous studies have shown that low-grade inflammation is associated with the risk of developing type 2 diabetes [3]. Furthermore, nowadays it is accepted that chronic subclinical inflammation is a part of the insulin resistance syndrome [4] and is strongly related to features of the metabolic syndrome [5]. The mechanisms by which chronic inflammation can evoke type 2 diabetes are not clear. However, it is known that adipose tissue can synthesize and release the main pro-inflammatory cytokines, tumour necrosis factor-alpha (TNF-α), interleukin-1 (IL-1) and interleukin-6 (IL-6), and that inflammatory markers are associated with body fat mass. Pro-inflammatory cytokines and acute phase reactants are involved in multiple metabolic pathways relevant to insulin resistance, including insulin regulation, reactive oxygen species, lipoprotein lipase action and adipocyte function [3]. Therefore, activated innate immunity and inflammation are relevant factors in the pathogenesis of diabetes, with convincing data that type 2 diabetes includes an inflammatory component [3,6]. Based on this new perspective of diabetes, the next question is clear: is inflammation related to the development of diabetic complications? Recent studies have shown that inflammation, and more specifically pro-inflammatory cytokines, play a determinant role in the development of microvascular diabetic complications. Diabetic neuropathy develops as a result of hyperglycaemia-induced local metabolic, enzymatic and microvascular changes. Pro-inflammatory cytokines are produced locally by resident and infiltrating cells. These molecules exhibit pleiotropic effects on homeostasis of glia and neurons in the central, peripheral and autonomic nervous systems. Changes induced by chronic hyperglycaemia lead to dysregulation of these cytokines. It has been demonstrated that endogenous TNF-α production is accelerated in microvascular and neural tissues, which may undergo increased microvascular permeability, hypercoagulability and nerve damage, thus initiating and promoting the development of characteristic lesions of diabetic polyneuropathy [7]. Regarding diabetic retinopathy, experimental animal investigations have shown that mRNA expression for IL-1 and TNF-α is increased in the retina early in the course of diabetes, and moreover, inhibition of TNF-α has demonstrated beneficial effects in the prevention of early diabetic retinopathy [8]. Clinical studies have shown elevated levels of pro-inflammatory cytokines in the vitreous fluid of patients with proliferative diabetic retinopathy, which are related with the activity and progression of retinal injury. These data highlighted the central and causal role of chronic low-grade subclinical inflammation in the pathogenesis of diabetic retinopathy [9]. A number of experimental and clinical studies have demonstrated that DN exhibits signs of inflammation. Three very recent papers illustrate the idea that inflammation plays a significant role in the pathogenesis of DN. Dalla Vestra and colleagues [10] showed that patients with type 2 diabetes and overt nephropathy exhibit the highest levels of diverse acute-phase markers of inflammation, including C-reactive protein (CRP), serum amyloid A (SAA), fibrinogen and IL-6. Furthermore, levels of CRP, SAA and IL-6 were higher in subjects with increased glomerular basement membrane (GBM) width. More important, the authors demonstrated the association between GBM thickening, a crucial lesion of diabetic glomerulopathy, and acute phase markers (fibrinogen and IL-6). In addition, two experimental studies provide insights into the way in which renal damage in diabetes is linked to inflammation. Chow et al. [11] showed that db/db mice, a model of type

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfi155

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 227

Metadata

Authors
Navarro, J. F., & Mora, C.
Venue
Nephrology Dialysis Transplantation
Published
2005-09-27
Volume
20
Issue
12
Pages
2601-2604
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W2111109876
Cited by
227
References
2
FWCI
4.14
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of inflammation in diabetic complications. https://app.cochat.ai/papers/10.1093/ndt/gfi155
The paper
Navarro, J. F., & Mora, C. (2005). Role of inflammation in diabetic complications. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfi155

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.